Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Alkermes Plc (ALKS)  
$24.68 0.24 (0.98%) as of 4:30 Fri 4/26


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 183,678,000
Market Cap: 4.53(B)
Last Volume: 775,760 Avg Vol: 773,595
52 Week Range: $23.37 - $33.63
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Delivery

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  581
Guru Rank Value     : 3
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   Alkermes is a biopharmaceutical company. Co. has a portfolio of marketed products focused on central nervous system disorders such as addiction and schizophrenia and a pipeline of product candidates in the fields of neuroscience and oncology. Co.'s proprietary products include: ARISTADA, which is an extended-release intramuscular injectable suspension approved in the U.S. for the treatment of schizophrenia; ARISTADA INITIO, which is indicated for the initiation of ARISTADA when used for the treatment of schizophrenia in adults; and VIVITROL, which is for the treatment of alcohol dependence and for the prevention of relapse to opioid dependence, following opioid detoxification.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 35,000
Total Buy Value $0 $0 $0 $815,735
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 15,666 15,666 89,488 206,962
Total Sell Value $454,291 $454,291 $2,700,159 $6,056,962
Total People Sold 3 3 4 6
Total Sell Transactions 3 3 7 12
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 2018
  Page 9 of 81  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Nichols Christian Todd SVP, Chief Commercial Officer   •       •      –    2022-06-05 4 OE $0.00 $0 D/D 3,500 29,538     -
   Landine Michael J SVP, Corp Dev., Alkermes, Inc.   •       •      –    2022-05-17 4 AS $29.15 $1,457,475 D/D (50,000) 232,306 -26%     
   Landine Michael J SVP, Corp Dev., Alkermes, Inc.   •       •      –    2022-05-17 4 OE $16.55 $827,500 D/D 50,000 282,306     -
   Landine Michael J SVP, Corp Dev., Alkermes, Inc.   •       •      –    2022-05-10 4 AS $27.22 $680,380 D/D (25,000) 232,306 -14%     
   Landine Michael J SVP, Corp Dev., Alkermes, Inc.   •       •      –    2022-05-10 4 OE $16.55 $413,750 D/D 25,000 257,306     -
   Landine Michael J SVP, Corp Dev., Alkermes, Inc.   •       •      –    2022-05-03 4 AS $28.62 $715,415 D/D (25,000) 232,306 -19%     
   Landine Michael J SVP, Corp Dev., Alkermes, Inc.   •       •      –    2022-05-03 4 OE $16.55 $413,750 D/D 25,000 257,306     -
   Cooke Shane Director   •       •      –    2022-05-02 4 AS $29.23 $292,330 D/D (10,000) 90,478 -16%     
   Cooke Shane Director   •       •      –    2022-05-02 4 OE $16.55 $165,500 D/D 10,000 100,478     -
   Cooke Shane Director   •       •      –    2022-04-25 4 AS $27.88 $278,849 D/D (10,000) 90,478 -14%     
   Cooke Shane Director   •       •      –    2022-04-25 4 OE $16.55 $165,500 D/D 10,000 100,478     -
   Jackson Blair Curtis EVP, Chief Operating Officer   •       •      –    2022-04-20 4 AS $29.61 $1,480,335 D/D (49,999) 87,915 -18%     
   Jackson Blair Curtis EVP, Chief Operating Officer   •       •      –    2022-04-20 4 OE $16.55 $827,483 D/D 49,999 137,914     -
   Cooke Shane Director   •       •      –    2022-04-18 4 AS $28.88 $288,750 D/D (10,000) 90,478 -15%     
   Cooke Shane Director   •       •      –    2022-04-18 4 OE $16.55 $165,500 D/D 10,000 100,478     -
   Cooke Shane Director   •       •      –    2022-04-11 4 AS $29.26 $292,601 D/D (10,000) 90,478 -13%     
   Cooke Shane Director   •       •      –    2022-04-11 4 OE $16.55 $165,500 D/D 10,000 100,478     -
   Cooke Shane Director   •       •      –    2022-04-04 4 AS $28.18 $281,845 D/D (10,000) 90,478 -9%     
   Cooke Shane Director   •       •      –    2022-04-04 4 OE $16.55 $165,500 D/D 10,000 100,478     -
   Snyderman Nancy Lynn Md Director   •       •      –    2022-03-04 4 B $23.43 $10,005 D/D 427 9,366 2.39 28%     
   Hopkinson Craig C. EVP R&D, Chief Medical Officer   •       •      –    2022-02-23 4 AS $24.76 $296,650 D/D (11,983) 17,994 30%     
   Hopkinson Craig C. EVP R&D, Chief Medical Officer   •       •      –    2022-02-22 4 D $25.01 $88,510 D/D (3,539) 29,977     -
   Hopkinson Craig C. EVP R&D, Chief Medical Officer   •       •      –    2022-02-22 4 OE $0.00 $0 D/D 12,037 33,516     -
   Gaffin David Joseph SVP, CLO, Alkermes, Inc.   •       •      –    2022-02-22 4 D $25.01 $53,596 D/D (2,143) 97,766     -
   Gaffin David Joseph SVP, CLO, Alkermes, Inc.   •       •      –    2022-02-22 4 OE $0.00 $0 D/D 7,286 99,909     -
  2018 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 9 of 81
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us